Veradermics MANE
NYSE MANE
$127.10 +4.82 (+3.94%)
As of: Oct 20, 2026 · 3:59 PM EDT

Veradermics (MANE) Share-based Compensation (2025 - 2026)

Updated

Veradermics' Share-based Compensation came in at $3.52 million for Q2 2026, compared with $115,000 a year earlier and down 33.1% from the prior quarter.

Analysis

Veradermics (MANE) Share-based Compensation (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Veradermics reported Share-based Compensation of $9.1 million; for FY2025, it was $1.44 million, up 476.0% from FY2024.

  • Going back by year, Share-based Compensation was $250,000 in FY2024.
  • The five-year range for quarterly Share-based Compensation is $115,000 (Q2 2025) to $5.26 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 458.00 Mn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 166.00 Mn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 231.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 249.00 Mn
10 Veradermics 5.17 Bn 3.77 Bn - 3.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.52 Mn
Mar 31, 2026 5.26 Mn
Jun 30, 2025 115,000.00
Mar 31, 2025 213,000.00
API Access

Veradermics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MANE&period=max&api_key=YOUR_API_KEY